Syndax Pharmaceuticals (SNDX) Other Non-Current Liabilities (2015 - 2020)

Syndax Pharmaceuticals' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1000.0 for Q4 2020.

• In Q4 2020, Other Non-Current Liabilities fell 80.0% year-over-year to $1000.0; the TTM figure through Dec 2020 stood at $1000.0 (down 80.0% YoY), while the FY2020 annual figure was $1000.0, down 80.0% from the prior year.
• Other Non-Current Liabilities was $1000.0 for Q4 2020 at Syndax Pharmaceuticals, down from $2000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $312000.0 in Q1 2018 to a low of $1000.0 in Q4 2020.
• Historically, Other Non-Current Liabilities has averaged $143350.0 across 5 years, with a median of $148000.0 in 2017.
• The sharpest annual moves came in 2018 and 2019: Other Non-Current Liabilities soared 110.81% in 2018, then slumped 97.76% in 2019.
• A 5-year view of Other Non-Current Liabilities shows it stood at $288000.0 in 2016, then climbed by 7.64% to $310000.0 in 2017, then slumped by 56.13% to $136000.0 in 2018, then slumped by 96.32% to $5000.0 in 2019, then plunged by 80.0% to $1000.0 in 2020.
• The last three Other Non-Current Liabilities figures came in at $1000.0 (Q4 2020), $2000.0 (Q3 2020), and $3000.0 (Q2 2020), per Business Quant data.